<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: This study examined the relationship, if any, between <z:chebi fb="105" ids="17234">glucose</z:chebi>-induced <z:mp ids='MP_0003674'>oxidative stress</z:mp>, <z:chebi fb="11" ids="22586">antioxidant</z:chebi> status and <z:mp ids='MP_0002959'>microalbuminuria</z:mp> in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The study involved 99 consecutive type 2 diabetic patients (57 men, 42 women) </plain></SENT>
<SENT sid="2" pm="."><plain>Patients with persistent <z:mp ids='MP_0002959'>microalbuminuria</z:mp> were identified and the following variables evaluated: fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi>, HbA(1c), malonyldialdehyde (<z:chebi fb="14" ids="32506">MDA</z:chebi>), pentosidine, AGE, the total radical-trapping <z:chebi fb="11" ids="22586">antioxidant</z:chebi> parameter (TRAP), vitamin E, <z:chebi fb="0" ids="16737">creatinine</z:chebi>, estimated GFR and <z:chebi fb="23" ids="18059">lipid</z:chebi> profile </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Patients were divided into two groups, i.e. 37 individuals without <z:mp ids='MP_0002959'>microalbuminuria</z:mp> (AER &lt;20 microg/min) and 62 with <z:mp ids='MP_0002959'>microalbuminuria</z:mp> (AER &gt; or =20 microg/min) </plain></SENT>
<SENT sid="4" pm="."><plain>The following variables were significantly higher in patients with <z:mp ids='MP_0002959'>microalbuminuria</z:mp> than in those without <z:mp ids='MP_0002959'>microalbuminuria</z:mp> (mean +/- SD): fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> 9.41 +/- 2.88 vs 8.19 +/- 1.93 mmol/l, p &lt; 0.05; HbA(1c) 7.97 +/- 1.51 vs 7.39 +/- 1.03%, p &lt; 0.05; <z:chebi fb="14" ids="32506">MDA</z:chebi> 1.18 +/- 0.35 vs 1.02 +/- 0.29 micromol/l, p &lt; 0.05; pentosidine 98.5 +/- 24.6 vs 82.9 +/- 20.9 pmol/ml, p &lt; 0.005; and AGE 13.2 +/- 4.8 vs 10.6 +/- 3.8 microg/mg protein, p &lt; 0.01 </plain></SENT>
<SENT sid="5" pm="."><plain>However, vitamin E and TRAP did not differ between the two groups </plain></SENT>
<SENT sid="6" pm="."><plain>Serum <z:chebi fb="0" ids="16737">creatinine</z:chebi> values and estimated GFR were similar in the two groups </plain></SENT>
<SENT sid="7" pm="."><plain>Only in patients with <z:mp ids='MP_0002959'>microalbuminuria</z:mp> were significant linear correlations seen between AER and both oxidation (HbA(1c) r = 0.33, p &lt; 0.01; <z:chebi fb="14" ids="32506">MDA</z:chebi> r = 0.59, p &lt; 0.001; pentosidine r = 0.48, p &lt; 0.001; and AGE r = 0.44, p &lt; 0.001) and antioxidation variables (vitamin E r = -0.55, p &lt; 0.001; TRAP r = -0.49, p &lt; 0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>Considering <z:hpo ids='HP_0000001'>all</z:hpo> variables together, multiple regression revealed a correlation between <z:mp ids='MP_0002959'>microalbuminuria</z:mp> and vitamin E, TRAP, HbA(1c) and <z:chebi fb="14" ids="32506">MDA</z:chebi>, but not pentosidine or AGE </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS/INTERPRETATION: Our data suggest that <z:mp ids='MP_0002959'>microalbuminuria</z:mp> in type 2 diabetic patients might be promoted by an insufficient counter-regulation of the <z:chebi fb="11" ids="22586">antioxidant</z:chebi> system in the event of increased glyco-oxidation/glycation </plain></SENT>
</text></document>